The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.

The first Phase 3 data for a cancer vaccine has raised questions about whether the potential new treatment is needed.

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketwatch.com)